FDA-Drug2019-10-16Class II
Rifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103; NDC 67457-445-60.
Mylan Laboratories Limited (Sterile Products Division)
Hazard
Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product.
Sold states
Nationwide in the USA
Affected count
19,165 vials
Manufactured in
Opp. Iim-B, Bilekahalli , Bannerghatta Road, N/A, Bangalore, N/A, India
Products
Rifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103; NDC 67457-445-60.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0139-2020Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief